EX-23.1 7 a19-3464_1ex23d1.htm EX-23.1

Exhibit 23.1


Consent of Independent Registered Public Accounting Firm


ContraVir Pharmaceuticals, Inc.

Edison, New Jersey


We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 13, 2019, relating to the consolidated financial statements of ContraVir Pharmaceuticals, Inc., which is incorporated by reference in that Prospectus. Our report on the consolidated financial statements contain an explanatory paragraph regarding the Company’s ability to continue as a going concern.


We also consent to the reference to us under the caption “Experts” in the Prospectus.



Woodbridge, New Jersey


April 18, 2019